ReviewJournal of experimental & clinical cancer research : CR2022

Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy.

Lingyue Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.